Institutional investors purchased a net $4.4 million shares of EXAS during the quarter ended September 2013 and now own 90.69% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST TRUST ADVISORS LP Bought 2.8 Million shares of Exact Sciences Corp
COLUMBUS CIRCLE INVESTORS Bought 1.3 Million shares of Exact Sciences Corp
683 CAPITAL MANAGEMENT LLC Bought 940.0 Thousand shares of Exact Sciences Corp